CORVUS PHARMACEUTICALS INC. - COMMON STOCK

Corvus Pharmaceuticals Presents Updated Data from Mupadolimab (Anti-CD73) Phase 1/1b Clinical Trial at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

12 Nov 2021 07:00:02 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Present at the Jefferies London Healthcare Conference

10 Nov 2021 16:05:00 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Present Updated Mupadolimab (Anti-CD73) Data at 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

02 Nov 2021 16:05:01 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2021 Financial Results

01 Nov 2021 16:05:00 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for Phase 1/1b Clinical Trial of ITK Inhibitor CPI-818 in China

27 Oct 2021 16:05:01 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Updates on Mupadolimab (Anti-CD73) Programs in Oncology and Infectious Disease

22 Sep 2021 06:00:00 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences

07 Sep 2021 16:05:00 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-818 in China

16 Aug 2021 17:00:00 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results

02 Aug 2021 16:05:01 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals Discontinues Phase 3 Study of Mupadolimab (Anti-CD73) for COVID-19 Due to Vaccine Effectiveness in Reducing Hospitalizations

15 Jul 2021 16:05:00 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

25 May 2021 16:05:00 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals Completes Sale of $10 Million Through Its ATM Program

05 May 2021 09:00:01 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results

29 Apr 2021 16:05:01 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results

25 Mar 2021 08:30:00 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences

05 Mar 2021 08:30:00 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock

17 Feb 2021 16:10:00 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock

12 Feb 2021 09:00:00 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock

11 Feb 2021 16:01:00 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with COVID-19

04 Feb 2021 07:30:00 By Nasdaq GlobeNewswire